Is this your brand? Sign in to claim ownership.
Sign in to claim this brandMicro Therapeutics, Inc.
US
Last updated May 24, 2026
What Micro Therapeutics, Inc. makes
Micro Therapeutics, Inc. manufactures neurovascular embolization coils, including detachable systems for treating cerebral aneurysms, and bare-metal intracranial vascular stents for stabilizing blood vessels in the brain. Their portfolio also includes non-neurovascular embolization coils for vascular occlusions outside the brain, as well as peripheral vascular intervention tools such as infusion catheters, thrombectomy wires, guide-catheters, and microcatheters for interventional radiology procedures. Additionally, they produce image-guided intravascular occluding balloon catheters for targeted vascular blockages.
The company’s devices are classified under FDA’s Class II and Class III regulatory categories, with most listed in the FDA’s Unique Device Identifier (UDI) database. Their products are designed for use in the United States, adhering to applicable medical device regulations.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- medtronic.com
- —
- —
- [email protected]
- Phone
- +1(800)633-8766
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 826110710
Catalogue (3141)
Page 1 of 63| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Pipeline | PED-325-16 | FDA UDI | Class III | Active |
| Pipeline | PED-500-10 | FDA UDI | Class III | Active |
| X-celeratorTM | 103-0602-300 | FDA UDI | Class II | Active |
| Axium | PC-16-40-3D | FDA UDI | Class II | Active |
| Concerto Detachable Coil System | NV-7-20-HELIX | FDA UDI | Class II | Unknown |
| Axium | QC-3.5-12-3D | FDA UDI | Class II | Active |
| Axium Prime | APB-4-12-3D-SS | FDA UDI | Class II | Active |
| Axium | PC-6-10-3D | FDA UDI | Class II | Active |
| AxiumTM | APB-1-2-3D-ES | FDA UDI | Class II | Active |
| Axium | NC-4-10-HELIX | FDA UDI | Class II | Active |
| Axium | QC-12-30-HELIX | FDA UDI | Class II | Active |
| HyperGlideTM | 104-4520 | FDA UDI | Class II | Active |
| Axium™ Detachable Coil System | PC-7-30-HELIX | FDA UDI | Class II | Active |
| Cragg-McNamara | 41032-01 | FDA UDI | Class II | Active |
| Pipeline TM Flex Embolization Device with Shield Technology TM | PED2-425-10 | FDA UDI | Class III | Active |
| Axium™ Detachable Coil System | NC-2-2-HELIX | FDA UDI | Class II | Active |
| Pipeline | PED-450-30 | FDA UDI | Class III | Active |
| Axium™ Prime Detachable Coil System | APB-2.5-4-HX-ES | FDA UDI | Class II | Active |
| AxiumTM | APB-3.5-6-3D-ES | FDA UDI | Class II | Active |
| AxiumTM | QC-14-30-3D | FDA UDI | Class II | Active |
| Pipeline | FA-71350-35 | FDA UDI | Class III | Active |
| Axium Detachable Coil System | QC-2-6-3D | FDA UDI | Class II | Active |
| MarathonTM | 105-5055 | FDA UDI | Class II | Active |
| Axium™ Detachable Coil System | PC-3-8-HELIX | FDA UDI | Class II | Active |
| ConcertoTM | PV-8-20-3D | FDA UDI | Class II | Active |
| Pipeline | FA-71450-25 | FDA UDI | Class III | Active |
| Axium PrimeTM | FC-4-12-3D | FDA UDI | Class II | Active |
| AxiumTM | QC-2.5-6-HELIX | FDA UDI | Class II | Active |
| Rebar | 105-5080-153C | FDA UDI | Class II | Active |
| X-Pedion | 103-0605-200 | FDA UDI | Class II | Active |
| ConcertoTM | PV-4-8-3D | FDA UDI | Class II | Active |
| Axium | QC-9-30-HELIX | FDA UDI | Class II | Active |
| Pipeline | FA-77300-16 | FDA UDI | Class III | Active |
| PipelineTM Flex Embolization Device with Shield TechnologyTM | PED2-425-14 | FDA UDI | Class III | Active |
| AxiumTM | QC-4-12-HELIX | FDA UDI | Class II | Active |
| Solitaire™ X-PACK | XPACK204 | FDA UDI | Class II | Active |
| Nxt | N-3-12-T10 | FDA UDI | Class II | Active |
| PipelineTM Vantage Embolization Device with Shield TechnologyTM | PED3-021-350-10 | FDA UDI | Class III | Active |
| Axium™ Detachable Coil System | PC-2-1-HELIX | FDA UDI | Class II | Active |
| AxiumTM | PC-2-6-HELIX | FDA UDI | Class II | Active |
| Concerto Detachable Coil System | PV-7-30-3D | FDA UDI | Class II | Active |
| ConcertoTM | PV-2-6-3D | FDA UDI | Class II | Active |
| AxiumTM | APB-2-4-3D-ES | FDA UDI | Class II | Active |
| Pipeline | FA-77500-18 | FDA UDI | Class III | Active |
| Axium Detachable Coil System | QC-4-8-3D | FDA UDI | Class II | Active |
| Axium PrimeTM | FC-5-15-3D | FDA UDI | Class II | Active |
| Pipeline | FA-77425-10 | FDA UDI | Class III | Active |
| Pipeline TM Flex Embolization Device with Shield Technology TM | PED2-350-14 | FDA UDI | Class III | Active |
| Marksman | FA-55150-1030 | FDA UDI | Class II | Active |
| ConcertoTM | PV-2-6-3D | FDA UDI | Class II | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (9)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
Micro Therapeutics, Inc. has nine FDA recall records initiated between July 13, 2021, and January 30, 2025. The records include both open and classified statuses, with reasons involving packaging exposure during transport, misalignment of product labeling (including size/configuration and international distribution discrepancies), and potential structural issues such as push wire fractures in delivery systems and embolization device malformations. The recalls address microcatheters, detachable coil systems, and embolization devices.
AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Jan 30, 2025 | Z-1246-2025 | — | open, classified | Use of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or serious adverse events. Higher risk in females less-than-or-equal-to 45 years of age |
| Jan 30, 2025 | Z-1245-2025 | — | open, classified | Use of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or serious adverse events. Higher risk in females less-than-or-equal-to 45 years of age |
| Jan 11, 2024 | Z-1253-2024 | — | open, classified | European version of microcatheter were distributed within US which contain a different "Indications for Use". |
| Jan 11, 2024 | Z-1252-2024 | — | open, classified | European version of microcatheter were distributed within US which contain a different "Indications for Use". |
| Jun 30, 2022 | Z-1557-2022 | — | open, classified | Outer carton packaging of microcatheters were exposed to wet substance during transport. |
| Jun 30, 2022 | Z-1556-2022 | — | open, classified | Outer carton packaging of microcatheters were exposed to wet substance during transport. |
| Apr 27, 2022 | Z-1261-2022 | — | open, classified | Due to incorrect size and configuration labeling of the detachable coil system. |
| Jul 13, 2021 | Z-2403-2021 | — | open, classified | Due to potential push wire fractures in the delivery system during use. The issue presents as a fracture in the spiral cut area of the Hypotube. |
| Jul 13, 2021 | Z-2402-2021 | — | open, classified | Due to potential push wire fractures in the delivery system during use. The issue presents as a fracture in the spiral cut area of the Hypotube. |